• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • Fabry Disease Companies

    ID: MRFR/HC/5599-HCR
    90 Pages
    Kinjoll Dey
    September 2025

    Fabry disease is a rare genetic disorder characterized by the accumulation of a specific type of fat in the body's cells, leading to a range of symptoms that can affect various organs. Companies involved in Fabry disease typically focus on the development of therapies, diagnostic tools, and research initiatives to improve the understanding and management of this rare disorder.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Fabry Disease Market Research Report – Forecast till 2034 Infographic
    Summary Table of Contents Segmentation Infographic

    Top Industry Leaders in the Fabry Disease Market

    Fabry Disease Key Companies

     

    Latest Fabry Disease Companies Update


    January 2024:A Phase 1/2a trial evaluating AMT-191 gene therapy for Fabry disease patients has been cleared by the FDA. This marks a significant step forward in potential curative options for the condition.December 2023:Research suggests that identifying small fiber neuropathy could help with early diagnosis and timely treatment initiation for Fabry patients.October 2023:A study was published identifying a new genetic mutation associated with Fabry disease, potentially paving the way for targeted therapy development.September 2023:Amicus Therapeutics presented positive data from their Phase 3 study on ATG-023 for Fabry patients with neuropathic pain, highlighting potential for additional treatment options.August 2023:Sanofi partnered with the Chordoma Foundation to support research and development efforts for Fabry disease management.

     

    List of Fabry Disease Key Companies in the Market



    • Amgen Inc.

    • Amicus Therapeutics Inc.

    • Bristol-Myers Squibb Company

    • GlaxoSmithKline

    • iBio

    • Neuraltus Pharmaceuticals

    • Novartis AG

    • Pfizer Inc.

    • AVROBIO

    • Idorsia Pharmaceuticals Ltd

    • Protalix

    • Sanofi

    • Shire

    • Takeda Pharmaceutical Company Limited

    • Teva Pharmaceutical Industries Ltd